CORARE LTD
CoRare is a UK-based digital health company that builds a platform connecting rare-disease patients and structuring real-world data for use in clinical research and patient care. Founded in 2025 and headquartered in Newcastle Upon Tyne, it operates at pre-seed stage.
- Company typePrivate
- Founded2025
- HeadquartersNewcastle Upon Tyne, United Kingdom
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
CORARE LTD firmographics
Firmographics- Name
- CORARE LTD
- Website
- https://corare.com
- Company type
- Private
- Founded year
- 2025
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- CoRare is a UK-based digital health company that builds a platform connecting rare-disease patients and structuring real-world data for use in clinical research and patient care. Founded in 2025 and headquartered in Newcastle Upon Tyne, it operates at pre-seed stage.
- Ownership category
- akta.pro rank
CORARE LTD industry classification
Industry- Product category
- Digital Health — Real-World Data Platform for Rare Disease
- NAICS
- Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518210)
- SIC
- Services-Computer Processing & Data Preparation (7374)
- akta.pro primary industry
- Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D) (HLAGAJAF)
- akta.pro secondary industry
- Data Access, Sharing & Marketplace Platforms (incl. TEFCA/QHIN enablement) (HLACAIAL)
Keywords
Where CORARE LTD is headquartered
LocationHeadquarters
- HQ city
- Newcastle Upon Tyne
- HQ country
- United Kingdom
- HQ region
- Europe
Markets served
CORARE LTD business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations
CORARE LTD product offering
Product offeringCore offering
CoRare operates a digital health platform that connects rare disease patients and structures real-world data for clinical research and care. The platform aggregates patient information and makes it usable for research workflows targeting rare conditions.
Differentiator
Problem solved
Functional benefit
Companies that use CORARE LTD
Customer profileIdeal customer profiles2 records
CORARE LTD technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
CORARE LTD competitors and assessment
Company assessmentEmerging players
- Flatiron Health: Flatiron Health (Roche) builds oncology-specific real-world datasets for research — a comparable data-structuring-for-research model, though focused on oncology rather than rare diseases.
- Tempus: Tempus operates a multiomics-and-clinical-data platform used for research and trial matching; partial overlap through the patient-cohort-to-RWD pipeline relevant to rare-disease research customers.
Broad incumbents
- Medidata (Dassault Systèmes): Medidata provides clinical-trial data and EDC platforms used across pharma; relevant as the established platform incumbent in the clinical-research data infrastructure that CoRare's RWD product would interface with or substitute.
- Veeva Systems: Veeva provides clinical-data, EDC, and trial-management software to pharma; relevant as a broad incumbent in healthcare R&D data infrastructure that defines the technical and commercial bar CoRare would need to meet.
- IQVIA: IQVIA is a global CRO and real-world-data incumbent serving pharma across the full R&D lifecycle; it represents the scaled incumbent whose RWD offerings CoRare would compete against for pharma research contracts.
Direct peers
- Trial Library (Antidote.me): Antidote (now part of Trial Library) operated a patient-matching and clinical-trial-recruitment platform with particular depth in rare and hard-to-recruit indications — directly comparable to CoRare's 'connects rare disease patients' value stream.
- Clara Health: Clara Health focuses on rare-disease patient recruitment and clinical-trial matching, directly overlapping with CoRare's patient-connection and trial-enablement thesis.
- TriNetX: TriNetX operates a real-world-data network used by pharma for clinical trial feasibility, cohort design, and evidence generation — the closest peer to CoRare's 'structures real-world data for clinical research' positioning.
- Centogene: Centogene operates a rare-disease diagnostic and real-world-data platform aggregating multiomic and clinical data to support pharma R&D, comparable to CoRare's combined rare-disease + structured RWD model.
- Mendelian: Mendelian combines rare-disease diagnostic decision support with structured real-world data capture for research — a UK-headquartered, near-identical model of rare-disease patient connection plus structured clinical data.
Market position
Customer concentration
CORARE LTD social profiles
Digital presenceCORARE LTD financial estimates
Financial estimateRevenue estimate
Valuation estimate
CORARE LTD leadership team
Management profileNumber of profiles
CORARE LTD funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CORARE LTD M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CORARE LTD
What does CORARE LTD do?
CoRare operates a digital health platform that connects rare disease patients and structures real-world data for clinical research and care. The platform aggregates patient information and makes it usable for research workflows targeting rare conditions.
When was CORARE LTD founded?
CORARE LTD was founded in 2025. It employs 1 to 10 people.
Where is CORARE LTD based?
CORARE LTD is headquartered in Newcastle Upon Tyne, United Kingdom, in the Europe region.
Who are CORARE LTD's main competitors?
Emerging players on record are Flatiron Health and Tempus. Broad incumbents are Medidata (Dassault Systèmes), Veeva Systems and IQVIA. Direct peers are Trial Library (Antidote.me), Clara Health, TriNetX, Centogene and Mendelian.
Does CORARE LTD have an API?
No public API is recorded for CORARE LTD.
What industry is CORARE LTD in?
CORARE LTD's product category is Digital Health — Real-World Data Platform for Rare Disease. Its primary akta.pro industry code is HLAGAJAF, Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D), with a secondary code of HLACAIAL, Data Access, Sharing & Marketplace Platforms (incl. TEFCA/QHIN enablement). Its NAICS code is 518210 and its SIC code is 7374.